Tract hemostasis using radiofrequency ablation for hepatic arterial bleeding after percutaneous transhepatic portal embolization
A 62-year-old man with colorectal liver metastases received multiple chemotherapy, hepatic arterial chemotherapy, and radiotherapy for 28 months. We planned a two-stage hepatectomy after percutaneous transhepatic portal embolization (PTPE) (1). The Glissonean capsule was hard, but ipsilateral PTPE was completed with a gelatin sponge and ethanolamine oleate under balloon occlusion (2). However, massive arterial bleeding was detected by Doppler ultrasonography after removal of the sheath (Figure 1A). We inserted a radiofrequency ablation (RFA) electrode (15 mm radiofrequency range) into the bleeding site (Figure 1B). We used the radiofrequency (RF) generator (VIVA RFA System, STARmed, Gyeonggi-do, South Korea) and 60 and 100 W power for 30 seconds each. The immediate hemostasis was confirmed (Figures 1C,2). A two-stage hepatectomy was completed. The Japanese guideline showed PTPE-related serious complication rates were 0.4–12.8%, including intra-abdominal hemorrhage, and recommended emergent arterial embolization for pseudoaneurysm rupture and open surgery for other situations (3). We reported that only 1.8% of patients experienced transient intra-abdominal hemorrhage (2). Stiff Glissonean capsule with histologically marked fibrosis and thickening induced by prior radiotherapy and hepatic arterial chemotherapy caused arterial hemorrhage (4). RFA following Doppler ultrasonography can control portal, arterial, and venous bleeding. An RFA system should be set up in the interventional radiology room.


Acknowledgments
None.
Footnote
Provenance and Peer Review: This article was a standard submission to the journal. The article has undergone external peer review.
Peer Review File: Available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-2025-194/prf
Funding: None.
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-2025-194/coif). The authors have no conflicts of interest to declare.
Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Written informed consent was obtained from the patient for publication of this manuscript and any accompanying image resources.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Shimizu T, Aoki T, Ishizuka M, Sakamoto K, et al. Evaluation of two-stage hepatectomy using portal vein embolization for colorectal liver metastasis: a retrospective nationwide cohort survey in Japan. Int J Surg 2024;110:6691-701. [Crossref] [PubMed]
- Beppu T, Iwatsuki M, Okabe H, et al. A new approach to percutaneous transhepatic portal embolization using ethanolamine oleate iopamidol. J Gastroenterol 2010;45:211-7. [Crossref] [PubMed]
- Hashimoto M, Ouchi Y, Yata S, et al. The Guidelines for Percutaneous Transhepatic Portal Vein Embolization: English Version. Interv Radiol (Higashimatsuyama) 2024;9:41-8. [Crossref] [PubMed]
- Juntermanns B, Grabellus F, Zhang H, et al. Vascular and nerval damage after intraoperative radiation therapy of the liver hilum in a large animal model. J Invest Surg 2014;27:163-8. [Crossref] [PubMed]